Best Peptides for Anti-Aging & Longevity: A Ranked Guide
The most evidence-backed anti-aging peptides — SS-31, MOTS-C, Humanin, Epitalon, and NAD+ — ranked by mechanism quality and evidence grade with honest caveats.
Anti-aging peptide research has converged on a clear theme: mitochondria. SS-31, MOTS-C, and Humanin are all mitochondria-targeted or mitochondria-derived peptides with meaningful evidence grades (Grade A, B, and A respectively) that work at the level where cellular aging begins — energy production efficiency, oxidative stress, and metabolic flexibility.
This guide ranks anti-aging peptides by evidence quality and specificity of mechanism, not by popularity. Some well-known 'longevity' compounds have weaker evidence than less-discussed ones. Where a compound targets aging through a specific mechanism (telomere extension, gene regulation), that's identified clearly.
Evidence Grade Key
⚠ Medical disclaimer: Research peptides discussed here are not FDA-approved for the uses described (exceptions noted). All dosing figures are common reference ranges from research and community literature — not medical prescriptions. Always discuss any compound protocol with a qualified healthcare provider before starting.
Ranked by Evidence
Mitochondrial Peptide · Anti-aging
Grade A — directly targets mitochondrial inner membranes, restores ATP production, and reduces oxidative stress at the source of cellular aging.
SS-31 selectively concentrates in the inner mitochondrial membrane where it binds cardiolipin — a critical phospholipid that anchors the electron transport chain complexes. Age-related oxidative damage to cardiolipin impairs ATP synthesis and increases reactive oxygen species. SS-31 stabilizes cardiolipin and restores the architecture of the electron transport chain, improving ATP output and reducing mitochondrial ROS. Human cardiac trials show meaningful functional improvements.
Reference Dose
0.5–1 mg/day
Some practitioners use 3–5 days per week rather than daily.
Route
Subcutaneous
Best for
The foundational anti-aging stack — particularly valuable for cardiovascular health, exercise capacity, and anyone with documented mitochondrial dysfunction.
Caveat
Expensive. Human trials focused primarily on cardiac patients; direct longevity data in healthy adults is limited. The mechanistic evidence is Grade A quality.
Mitochondrial Peptide · Metabolic / Anti-aging
A mitochondria-encoded exercise-mimetic that declines with age — restoring it improves insulin sensitivity, fat metabolism, and exercise capacity.
MOTS-C is a 16-amino acid peptide encoded within mitochondrial DNA that functions as a systemic metabolic regulator. It activates AMPK signaling pathways, promoting fatty acid oxidation, improving insulin sensitivity, and enhancing mitochondrial biogenesis. Serum MOTS-C levels decline significantly with aging and correlate with metabolic deterioration.
Reference Dose
0.5–5 mg per dose, 2–3×/week
Exercise potentiates MOTS-C's effects — timing around training is recommended.
Route
Subcutaneous
Best for
Metabolic aging, age-related insulin resistance, declining exercise capacity, and overall healthspan improvement.
Caveat
Grade B reflects animal models and limited human data. Long-term human safety profile not established.
Mitochondrial Peptide · Neuroprotection / Longevity
A mitochondria-derived longevity signal — serum levels correlate with human lifespan in observational data, with neuroprotective and cardioprotective effects.
Humanin is a 21-amino acid peptide encoded in the mitochondrial 16S ribosomal RNA gene. It protects cells from apoptotic death triggered by oxidative stress and misfolded proteins — mechanisms central to neurodegeneration and cardiac disease. Human serum Humanin levels are inversely correlated with disease risk and directly correlated with longevity phenotypes in large observational studies.
Reference Dose
0.25–1 mg/day
Route
Subcutaneous
Best for
Neuroprotection, cardiovascular aging, and anyone building a comprehensive mitochondrial longevity stack.
Caveat
Despite Grade A evidence quality, most human data is observational rather than interventional. Interventional trials in healthy adults are limited.
Telomerase Activator · Circadian / Longevity
The most studied telomerase-activating peptide — extends telomere length and regulates pineal melatonin production in animal and early human data.
Epitalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) that activates telomerase, the enzyme responsible for maintaining telomere length. Telomere shortening is a primary hallmark of aging. Epitalon also stimulates melatonin synthesis in the pineal gland, supporting circadian rhythm regulation — a dimension of aging distinct from mitochondrial function.
Reference Dose
5–10 mg per dose, 10 days on / 3 months off
Commonly used in 10-day courses rather than daily continuous dosing.
Route
Subcutaneous
Best for
Telomere length maintenance, sleep quality improvement (pineal regulation), and anyone building a multi-mechanism anti-aging protocol.
Caveat
Grade C — most data from Russian research groups. Theoretical concern about telomerase activation in cancer risk contexts, though preclinical data shows anti-tumor properties.
NNMT Inhibitor · Experimental
Experimental NNMT inhibitor that may increase intracellular NAD+ and reduce metabolic dysfunction associated with aging adipose tissue.
5-Amino-1MQ inhibits NNMT (nicotinamide N-methyltransferase), an enzyme overexpressed in aging adipose tissue that depletes NAD+ precursors and promotes metabolic dysfunction. By inhibiting NNMT, it may support NAD+ availability and reduce the metabolic deterioration associated with aging fat tissue.
Reference Dose
50–150 mg/day
Route
Oral
Best for
Those interested in NAD+ pathway support through the NNMT mechanism. Highly experimental — not a primary intervention.
Caveat
Grade E — zero human clinical trial data. All data from rodent models. Combine with an established NAD+ precursor (NMN/NR) rather than relying on this alone.
Conclusion
The most evidence-backed anti-aging stack centers on mitochondrial function: SS-31 (Grade A), MOTS-C (Grade B), and Humanin (Grade A) address the root mechanisms of cellular aging at the organelle level. Epitalon adds telomere and circadian rhythm dimensions. NAD+ is the accessible, well-tolerated foundation layer that most protocols include. Choose compounds based on mechanism specificity and honest evidence grades — not on marketing claims.
Frequently Asked Questions
What's the most important anti-aging peptide to start with?
SS-31 and MOTS-C are the most evidence-backed starting points because their mechanisms address the root drivers of cellular aging. If budget is a constraint, NAD+ precursors (NMN/NR oral) are more accessible and have meaningful Grade B evidence for metabolic and cognitive aging. Epitalon is worth adding for telomere support and sleep quality — particularly for those over 45.
Do anti-aging peptides actually extend lifespan in humans?
No human lifespan trial data exists — such a trial would take decades. What we have is mechanistic evidence (addressing known aging pathways), animal lifespan data (SS-31, MOTS-C, Humanin all extend lifespan in animal models), and human biomarker data. The honest answer is: compelling mechanisms, no human lifespan proof.
Should I be concerned about Epitalon activating telomerase given cancer risks?
Telomerase activation is a legitimate theoretical concern since cancer cells often rely on telomerase to divide indefinitely. However, Epitalon's preclinical data includes anti-tumor properties in some models, not tumor promotion. The research community's current view is that the cancer risk from telomerase activation in healthy cells is theoretical and not well-supported. Individuals with active malignancy or high cancer risk should discuss with an oncologist before using Epitalon.
How do SS-31, MOTS-C, and Humanin work together?
SS-31 stabilizes the inner membrane architecture to restore ATP synthesis efficiency. MOTS-C activates AMPK-driven metabolic flexibility. Humanin protects cells from apoptotic energy depletion — particularly in neurons and cardiac cells. Together, they form a comprehensive mitochondrial support protocol addressing energy production, metabolic regulation, and cellular protection.
How long does it take to see results from anti-aging peptides?
Subjective improvements (energy, sleep quality, cognitive clarity) often emerge within 2–6 weeks. Objective biomarker changes typically require 8–16 weeks of consistent use. Anti-aging effects at the cellular level are cumulative over months to years — this is not a category where short cycles produce dramatic results.
Related Reading
Discuss Protocols with Real Practitioners
Join the Hacksmith's Peptalk community for in-depth peptide protocol discussions, dosing Q&As, and member experiences with every compound in this guide.
Join Skool Community →Free to join · No credit card
All dosing figures are educational reference ranges from research literature. Not medical prescriptions. Discuss any protocol with a qualified healthcare provider.